In Silico Molecular Docking Studies of Phytoconstituents Identified in Curcuma zedoaria Rosc. on Acetylcholinesterase: An Enzyme Target for Anti Alzheimer’s Activity
Keywords:
Acetylcholinesterase, Binding energy, Inhibition Constant, PhytoconstituentsAbstract
Alzheimer’s disease (AD) is a chronic, progressive and disabling organic brain disorder characterized by disturbances of multiple cortical functions. Acetylcholinesterase (AChE) inhibition is thought to be a promising approach towards the treatment of AD. The aim and objective of the present study is to perform in-silico docking analysis of the major active constituents identified in Curcuma zedoaria Rosc. against AChE for anti-Alzheimer’s activity. In this perspective, phytoconstituents like bisdemethoxy curcumin, curcumenone, curcuminolide-A, curcuminolide-B, demethoxy curcumin, eucalyptol and zingiberene were selected for the present study. Rivastigmine, a known AChE inhibitor was used as the standard. In-silico docking analysis was performed by using AutoDock 4.2 using Lamarckian genetic algorithm. The crystal structure of AChE (2WLS) was retrieved from brookhaeven protein data bank in pdb format. In the docking studies, docking parameters such as binding energy, inhibition constant and intermolecular energy were determined using AutoDock 4.2. Docking results of the selected phytoconstituents showed binding energy ranging between -5.47 and -8.04 kcal/mol when compared with that of the standard (-6.73 kcal/mol). Inhibition constant (98.31 to 1.28 μM) and intermolecular energy (-7.85 to -8.34 kcal/mol) of the phytoconstituents also coincide with the binding energy. These results clearly indicate that the phytoconstituents, especially, curcuminolide-A, curcuminolide-B and curcumenone have excellent binding sites and interactions with AChE compared to the standard. Further investigations on these compounds and in vivo studies are necessary to develop potential chemical entities in the management of Alzheimer’s disease.
Keywords: Acetylcholinesterase, binding energy, inhibition constant, phytoconstituents, curcuminolide, AutoDock
Cite this Article
Arumu gam Madeswaran, Lakshmi Menon .
In Silico Molecular Docking Studies of
Phytoconstituents Identified in Curcuma
zedoaria Rosc. on Acetylcholinesterase:
An Enzyme Target for Anti Alzheimer’s
Activity Research & Reviews: Journal of
Computational Biology. 2019; 8(3): 9 14 p.
References
Helman AM, Murphy MP. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Biochim. Biophys. Acta. 2016; 1862: 975–82p.
Winner B, Kohl, Gage FH. Neurodegenerative disease and adult neurogenesis. Eur. J. Neurosci. 2011; 33:1139-51p.
Lillberg K, Verkasalo PK, Kaprio J, et al. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol. 2003; 157: 415-23p.
Rahe RH. Life change events and mental illness: an overview. J Human Stress.1979; 5: 2-10p.
Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. 1999; 156: 837-41p.
Stamati K, Mudera V, Cheema U. Evolution of oxygen utilization in multicellular organisms and implications for cell signalling in tissue engineering. J Tissue Eng. 2011; 5–8p.
Catherine N, Miriam C, Clare H, David A. Oxidative phosphorylation, not glycolysis, powers pre- and postsynaptic mechanisms underlying brain information processing. J Neurosci. 2012; 32: 8940-51p.
Gnaiger E. Bioenergetics at low oxygen: dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. Respir Physiol. 2011; 128: 277-97p.
Gella A, Durany N. Oxidative stress in Alzheimer disease. J Tissue Eng. 2009; 3: 88-93p.
Beal MF Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2015; 58: 495-505p.
Wilson B. Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. J Ethnopharmacol. 2015; 99: 147–151p.
Maciel N., Criley RA. Morphology, growth and flowering behavior of Curcuma zedoaria. Acta Hort.2013; 624: 111–16p.
Etoh H. 9‐Oxo‐neoprocurcumenol from Curcuma aromatica (Zingibereaceae) as an attachment inhibitor against the blue mussel, Mytilus edulis galloprovincalis. Biosci Biotechnol Biochem. 2013; 67: 911–13p.
Konc J, Konc JT, Penca M, Janezic D. Binding-sites prediction assisting protein-protein docking. Acta Chim Slov.2011; 58: 396–401p.
Madeswaran A, Umamaheswari M, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P. In Silico docking studies of lipoxygenase inhibitory activity of commercially available flavonoids. Orient Pharm Exp Med. 2012; 12: 157-61p.
Prakhov ND, Chernorudskiy LA, Gainullin, RM. VSDocker: a tool for parallel high-throughput virtual screening using AutoDock on Windows-based computer clusters. Bioinformatics.2010; 26: 1374-75p.
Madeswaran A, Umamaheswari M, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P. Computational drug discovery of potential TAU protein kinase I inhibitors using in silico docking studies. Bangladesh J Pharmacol. 2013; 8: 131-5p.
Morris GM, Huey R, Lindstrom W, Sanner MF. AutoDock 4 and AutoDock Tools 4: automated docking with selective receptor flexibility. J Comput Chem. 2009; 8:2785-91p.
Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: Applications of Autodock. J Mol Recognit.1996; 6: 1-5p.
Cavasotto CN, Abagyan RA. Protein flexibility in ligand docking and virtual screening to protein kinases. J Mol Biol. 2004; 7: 209-25p.
Seeliger D, Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des.2010; 5:417-24p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |